Related Experiment Video
Updated: May 9, 2026

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Identifying associations between genomic alterations in tumors
Joshy George1, Kylie L Gorringe, Gordon K Smyth
1Cancer Genetics and Genomics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
Abstract:
Single-nucleotide polymorphism (SNP) mapping arrays are a reliable method for identifying somatic copy number alterations in cancer samples. Though this is immensely useful to identify potential driver genes, it is not sufficient to identify genes acting in a concerted manner. In cancer cells, co-amplified genes have been shown to provide synergistic effects, and genomic alterations targeting a pathway have been shown to occur in a mutually exclusive manner. We therefore developed a bioinformatic method for detecting such gene pairs using an integrated analysis of genomic copy number and gene expression data. This approach allowed us to identify a gene pair that is co-amplified and co-expressed in high-grade serous ovarian cancer. This finding provided information about the interaction of specific genetic events that contribute to the development and progression of this disease.
Insights
We developed a bioinformatic method to find co-amplified and co-expressed gene pairs in ovarian cancer. This approach identifies genes acting together, offering insights into cancer development and progression.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Biology
Background:
- Single-nucleotide polymorphism (SNP) mapping arrays identify somatic copy number alterations in cancer.
- Identifying genes acting in a concerted manner requires more than just copy number data.
- Co-amplified genes can have synergistic effects, while pathway-targeted alterations may be mutually exclusive.
Purpose of the Study:
- To develop a bioinformatic method for detecting co-amplified and co-expressed gene pairs.
- To integrate genomic copy number and gene expression data for enhanced analysis.
- To identify specific gene pairs involved in high-grade serous ovarian cancer.
Main Methods:
- Developed a novel bioinformatic approach.
- Integrated genomic copy number and gene expression datasets.
- Analyzed data to detect co-amplified and co-expressed gene pairs.
Main Results:
- Successfully identified a gene pair that is both co-amplified and co-expressed.
- The identified gene pair is prevalent in high-grade serous ovarian cancer.
- The findings highlight interactions between genetic events in cancer progression.
Conclusions:
- The developed bioinformatic method effectively identifies functionally related gene pairs.
- Co-amplification and co-expression of specific gene pairs are significant in ovarian cancer.
- This research provides insights into the genetic underpinnings of ovarian cancer development.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

